Upregulation of CISD2 in lung adenocarcinoma (ADC) specimens compared with their adjacent normal counterparts was found (33), and was associated with increased antioxidant capacity in response to elevated ROS levels during the formation and progression of lung cancer (33). This evidence concerns the gene CISD2 and lung carcinoma.